Iterum Therapeutics plc (ITRM)

Iterum Therapeutics Statistics

Total Valuation

ITRM has a market cap or net worth of $32.60 million. The enterprise value is $52.63 million.

Market Cap	32.60M
Enterprise Value	52.63M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ITRM has 44.66 million shares outstanding. The number of shares has increased by 107.59% in one year.

Current Share Class	44.66M
Shares Outstanding	44.66M
Shares Change (YoY)	+107.59%
Shares Change (QoQ)	+17.25%
Owned by Insiders (%)	0.92%
Owned by Institutions (%)	8.53%
Float	44.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.69

Current Ratio	2.69
Quick Ratio	2.37
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.69

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-46.16%
Return on Invested Capital (ROIC)	-56.49%
Return on Capital Employed (ROCE)	-62.48%
Revenue Per Employee	n/a
Profits Per Employee	-$2.68M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ITRM has paid $280,000 in taxes.

Income Tax	280,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.55% in the last 52 weeks. The beta is 3.23, so ITRM's price volatility has been higher than the market average.

Beta (5Y)	3.23
52-Week Price Change	-22.55%
50-Day Moving Average	0.72
200-Day Moving Average	1.10
Relative Strength Index (RSI)	50.15
Average Volume (20 Days)	822,360

Short Selling Information

The latest short interest is 1.27 million, so 2.85% of the outstanding shares have been sold short.

Short Interest	1.27M
Short Previous Month	1.37M
Short % of Shares Out	2.85%
Short % of Float	2.87%
Short Ratio (days to cover)	1.97

Income Statement

Revenue	n/a
Gross Profit	-941,000
Operating Income	-17.80M
Pretax Income	-23.80M
Net Income	-24.08M
EBITDA	-16.83M
EBIT	-17.80M
Earnings Per Share (EPS)	-$0.80

Balance Sheet

The company has $13.03 million in cash and $32.56 million in debt, giving a net cash position of -$19.53 million or -$0.44 per share.

Cash & Cash Equivalents	13.03M
Total Debt	32.56M
Net Cash	-19.53M
Net Cash Per Share	-$0.44
Equity (Book Value)	-3.89M
Book Value Per Share	-0.09
Working Capital	9.36M

Cash Flow

In the last 12 months, operating cash flow was -$14.74 million and capital expenditures -$2,000, giving a free cash flow of -$14.74 million.

Operating Cash Flow	-14.74M
Capital Expenditures	-2,000
Free Cash Flow	-14.74M
FCF Per Share	-$0.33

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ITRM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-107.59%
Shareholder Yield	-107.59%
Earnings Yield	-72.75%
FCF Yield	-44.54%

Analyst Forecast

The average price target for ITRM is $9.00, which is 1,133.05% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	1,133.05%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 18, 2022. It was a reverse split with a ratio of 1:15.

Last Split Date	Aug 18, 2022
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	2